Dr. Cansu Karakas, MD

Dr. Karakas practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Karakas' NPI, 1588280101, was assigned on June 19, 2020. Dr. Karakas holds California license A196849.

Dr. Karakas' primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Karakas' primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Karakas is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Karakas to 1 more hospital and 2 medical groups, each named with a free account. Dr. Karakas' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karakas practices, 3 sites in all. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Karakas' primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Karakas is board certified in pathology - anatomic by the American Board of Pathology. Dmand AI has Dr. Karakas' licenses on file in 2 states: California and Massachusetts.

CMS data shows 291 Medicare services from Dr. Karakas across 6 procedure codes in 2024, for 79 Medicare patients. Medicare paid $12,407 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Karakas in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have cancer, and 66% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Karakas' median patient age at 50, with 96% women.

Dr. Karakas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 25 papers to Dr. Karakas, published from 2016 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Biomarkers, Tumor and Cyclin E. Dr. Karakas has published most often in Cancer Res. Dr. Karakas' most frequent co-authors are Kelly K. Hunt, MD, Aysegul A. Sahin, MD and Bradley Monroe Turner, MD.

CMS Open Payments shows 1 general payment to Dr. Karakas from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $147.

Dr. Karakas is in network with 2 carriers, including Aetna and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.